key: cord-0769920-m4k8cqg7
authors: Schnuriger, Aurélie; Perrier, Marine; Marinho, Valérie; Michel, Yanne; Saloum, Kenda; Boukli, Narjis; Lambert-Niclot, Sidonie; Amiel, Corinne; Fofana, Djeneba Bocar; Gozlan, Joël; Morand-Joubert, Laurence
title: Caution in interpretation of SARS-CoV-2 quantification based on RT-PCR cycle threshold value
date: 2021-03-04
journal: Diagn Microbiol Infect Dis
DOI: 10.1016/j.diagmicrobio.2021.115366
sha: 5939476671c77af405007f0f68088feedee08558
doc_id: 769920
cord_uid: m4k8cqg7

RT-PCR is the reference method for diagnosis of a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) infection. During the setting up of 6 SARS-CoV-2 RT-PCR assays in our laboratory, comparative evaluations were systematically undertaken and allowed to evidence major discrepancies on cycle threshold RT-PCR results between techniques. These tendencies were confirmed in routine application when analyzing sequential samples from the same patients. Our aim was to examine the impact of the technique among factors influencing RT-PCR result, a far surrogate of ‘viral load’ in the heterogeneous environment of respiratory specimens.

In the setting of the world outbreak of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2), responsible for Coronavirus , nucleic acid testing is the standard method for acute infection diagnosis. SARS-CoV-2 RT-PCR result is sometimes referred to as 'viral load', whereas this term is often used in an inappropriate way.

Undeniably, SARS-CoV-2 RT-PCR results are expressed as cycle threshold (Ct) values, which can provide a semi-quantitative estimate of viral genome levels in clinical specimens However, several elements have to be considered for accurate use and interpretation of Ct values in this manner. First, as for all respiratory viruses, detection relies on the quality of sampling and experienced staff is required [1] . The possible joint amplification of a cellular gene indicates if cells are present, but not the cell type -not all are virus target cells.

Constraints concerning viral inactivation prior to extraction are taken into account individually in each laboratory and false negative results have been observed when using thermic inactivation [2] . Next, quality of RNA extraction fluctuates according to the method chosen, especially on respiratory specimens for which the viscosity may be elevated. For the RT-PCR itself, analytical sensitivity for most commercial assays is similar, generally around 100 RNA copies/reaction. However, this limit of detection is determined on plasmid or synthetic transcript sequential dilutions, not identical to extracted products from infected cells potentially containing large amounts of cellular derivatives. Finally, the designation 'viral load' is restricted to PCR performed with standards, allowing Ct translation into copies/ml [3] . Up to day many different type of standards exist, as elaboration of an international calibration standard is only under progress yet [4] . A growing literature describes comparisons between SARS-CoV-2 RT-PCR techniques (5) (6) (7) (8) , sometimes underlying discrepancies between assays. Our aim was to assess this issue in our local laboratory setting, to complete the analysis on clinical samples with quality controls and to highlight the importance of considering the RT-PCR performances when interpreting the Ct value.

During establishment of numerous SARS-CoV-2 RT-PCR assays in our laboratory since March 2020, comparative evaluations were systematically undertaken. Figure 1 summarizes comparisons performed between 4 RT-PCR assays (A to D) and 2 unitary rapid one-step extraction/RT-PCR assays (E and F). Techniques were chosen successively mainly according to announced performances and local equipment availability -allowing automation. The 6 assays were A-in-house RT-PCR based on gene E amplification [9] , B-Bosphore® v2 nCoV assay (Anatolia geneworks), C-Allplex TM nCoV assay (Seegene), D-RealTime SARS-CoV-2 assay on M2000 (Abbott), E-Xpert® Xpress SARS-CoV-2 assay (Cepheid) and F-Simplexa TM COVID-19 Direct (Diasorin molecular). All 6 assays were monitored by an internal control.

The initial evaluation was realized on samples selected in March and April 2020 for their (Figure 1 and 2) . These discrepancies could not be solely related to technical parameters of sample input and fraction of nucleic acid elution used as input in the PCR (Table 1) , as it is commonly admitted that a variation of a factor 10 in the genome quantity measurement is reflected by a variation of approximately 3 in the Ct value. Interestingly, when testing serial dilutions of both a clinical sample and a quality control sample (table 2) , a similar detection cut-off was measured, in accordance of limit of detection data announced by manufacturers and reported in Table 1 . The earlier Ct values obtained by technique D (M2000), and to a lesser extend F (Simplexa), were then not related to a better sensitivity. Additionally, reliability of the techniques over time was verified through the regular testing of an independent quality control (Qnostics © , Randox laboratories). Results on this quality control on a 6 months period allowed calculation of coefficients of variation of 3.5% (orf1) and 6.6% (gene E) for technique B (Bosphore); 4.0% (gene E), 3.5% (gene N) and 3.4% (gene RdRP) for technique C (Allplex); 1.7% (gene RdRP+N) for technique D (M2000). Coefficients of variation mainly below 5% attest to a satisfactory stability of the tests in time.

Moreover, in routine application during a 2-month study period (March -April 2020) with over 8000 RT-PCRs performed, we analyzed sequential samples from 833 patients and observed various temporal profiles. Apart from the sample collection issue, variations may reflect numerous factors including infection kinetics, clinical severity, immune response and potential treatments. We also evidence in this study the variation induced by the RT-PCR technique itself. Six representative patients, for whom longitudinal samples were processed by 2 different assays, are presented in Figure 3 . This selection consisted mostly of severe cases presenting prolonged viral excretion, as it has been previously described [10] . We observed the same individual evolution profiles by both assays, but confirmed quantitative Ct result differences with delta Ct of up to 15 on the same sample, and even a few qualitative discrepancies with samples found positive with one technique and negative with the other.

SARS-CoV-2 RT-PCR is the gold standard diagnosis method with high sensitivity. Numeric result of the RT-PCR, given as a Ct value, is assuredly informative about the level of genome quantity in the analyzed sample. Such information can be very useful for patient's management, especially during follow-up of severe infections. However, respiratory specimens represent heterogeneous environments, as described earlier for other respiratory viruses [11] . SARS-CoV-2 RT-PCR in respiratory samples with varied volume and cellularity, differ largely from standardized and repeatable viral loads in blood. SARS-CoV-2 RT-PCR Ct values only indicate a semi-quantitative evaluation of genome quantity and are influenced by many factors. Among those factors, our study and others highlight the importance of the RT-PCR method used [5] [6] [7] [8] . The potential patient contagiousness, evaluated in the foreground on clinical criteria and time from symptoms onset, cannot be determined on the sole RT-PCR Ct result and can also be partly estimated after inoculation in cell culture [12] . If PCR thresholds are given beyond which viral excretion can be estimated as low, they will remain strictly dependent on the technique used. As numerous kits are available worldwide, several techniques being even sometimes implemented in the same laboratory due to various local constraints, RT-PCR Ct values require informed interpretation. Such thresholds also remain restricted to sample type and sampling site. Furthermore, interpretation has to take into account the differential situation of a result on a single diagnosis sample and on iterative sampling from more severe patients. Any longitudinal monitoring should be based on the same technique in the same experimental conditions. In the absence of normalization of the SARS-CoV-2 RT-PCR Ct, decisions on the management of PCR positive patients remain challenging based on this data alone.

Aurélie Schnuriger and Laurence Morand-Joubert conceptualized the study. Aurélie 

Temporal profiles of SARS-CoV-2 RT-PCR cycle thresholds (Ct) for six representative patients.

Samples (nasopharyngeal swabs) were processed by 2 comparative assays: B-Bosphore v2 nCoV assay (Anatolia geneworks) or C-Allplex nCoV assay (Seegene), vs D-RealTime SARS-CoV-2 assay (Abbott) or F-Simplexa COVID-19 Direct (Diasorin molecular). 

Inappropriate Nasopharyngeal Sampling for SARS-CoV-2 Detection Is a Relevant Cause of False-Negative Reports

Potential False-Negative Nucleic Acid Testing Results for Severe Acute Respiratory Syndrome Coronavirus 2 from Thermal Inactivation of Samples with Low Viral Loads

RT-PCR for SARS-CoV-2: Quantitative versus Qualitative

Analytical Sensitivity and Efficiency Comparisons of SARS-CoV-2 RT-QPCR Primer-Probe Sets

Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in

Nasopharyngeal Specimens

Detection of 2019 Novel Coronavirus (2019-NCoV) by Real-Time RT-PCR

Interpreting Diagnostic Tests for SARS-CoV-2

Pitfalls in Interpretation of CT-Values of RT-PCR in Children with Acute Respiratory Tract Infections

The authors would like to acknowledge the staff at the virology laboratory for their strong commitment to this new coronavirus diagnosis activity for our patients.

The authors declare no conflict of interest.